BD to produce more than half of its products in Asia; Stentmaker raises $20 million;

@FierceMedDev: GE Healthcare, FBI allege Chinese engineer stole MRI trade secrets. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: EU creates €1B fund for research on the use of graphene. Article | Follow @VarunSaxena2

@MichaelGFierce: ICYMI: UO, Berkeley team tailors ultrathin peptoid nanosheets for delivery using oil and water. More from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: J&J ordered to fork over $3.27M in vaginal mesh case. Report | Follow @EmilyWFierce

> At the opening of an expanded facility in Singapore, Becton Dickinson ($BD) announced that it aims to make more than half of its products in Asia by 2024. Article

> Stentmaker Tryton Medical raised $20 million in private equity financing. Article

> Virginia Mason hospital in Seattle will offer warranties on hip and knee replacement surgeries. Article

Biotech News

@FierceBiotech: Christoph Westphal launches another biotech, with the help of some wealthy friends. Story | Follow @FierceBiotech

@JohnCFierce: Can Novo Nordisk and Orexigen finally open up a blockbuster weight-loss market? More | Follow @JohnCFierce

@DamianFierce: Hyperion says it was duped into signing a $570M deal for an Israeli biotech. Story | Follow @DamianFierce

@EmilyMFierce: Great tool for journalists covering NIH budget: @UMR4NIH launched an interactive map that breaks down state funding. More | Follow @EmilyMFierce

> OrbiMed Advisors banks $325M for a new round of Asian biotech bets. Report

> Boehringer's next-gen COPD treatment hits the mark in Phase III. Article

> PRA lines up a $375M IPO after a string of CRO deals. Story

Pharma News

@FiercePharma: Top-read on FP Monday: Bristol-Myers socks Merck's brand-new Keytruda with PD-1 patent suit. Article | Follow @FiercePharma

@EricPFierce: ICYMI yesterday: Action against AbbVie, Teva over AndroGel comes as FTC is stalking a $1B settlement this year. Report | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Latest Allergan buzz puts Ireland's Jazz in its dealmaking sights. Story | Follow @CarlyHFierce

> Feds eyed GlaxoSmithKline's Chinese consumer biz for bribery, too. Report

> Judge: Merck must fight claims that it lied about mumps vaccine benefits. Story

> NICE says 'too pricey' to Celgene's Abraxane combo for pancreatic cancer. Article

Biotech Research News

> Compound inhibits both MERS, SARS. Report

> Experimental C. difficile drugs could be more effective than current therapy. Article

> Glaxo's Ebola vaccine effective in monkeys but may require booster shot. More

> 'Disease in a dish' aids Huntington's drug discovery. Item

> Scientists find way to expand blood stem cell production in lab. Story

Pharma Manufacturing News

> ProBioGen will double its Berlin staff to expand cell-based manufacturing. Article

> Germany's Aenova buys North Carolina packaging operation. Item

> Cipla buys two Indian manufacturing facilities for partner Okasa. Story

> Perrigo recalls 367,000 tubes of nicotine lozenges. Report

> FDA, DOJ arrest NECC pharmacist about to leave the country. Article